CorVel Corp. (NASDAQ:CRVL – Get Free Report) VP Jennifer Yoss sold 2,100 shares of the business’s stock in a transaction dated Friday, November 13th. The stock was sold at an average price of $86.48, for a total value of $181,608.00. Following the transaction, the vice president directly owned 2,209 shares of the company’s stock, valued at approximately $191,034.32. The trade was a 48.74% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Jennifer Yoss also recently made the following trade(s):
- On Thursday, August 20th, Jennifer Yoss sold 2,100 shares of CorVel stock. The shares were sold at an average price of $70.92, for a total transaction of $148,932.00.
CorVel Stock Performance
Shares of CRVL traded up $1.65 during mid-day trading on Monday, reaching $87.34. The company had a trading volume of 231,461 shares, compared to its average volume of 213,674. The company has a market capitalization of $4.40 billion, a price-to-earnings ratio of 36.70 and a beta of 1.07. The company’s 50 day simple moving average is $77.63 and its 200 day simple moving average is $63.34. CorVel Corp. has a 1-year low of $44.83 and a 1-year high of $89.76.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the company. Bank of America Corp DE acquired a new stake in shares of CorVel in the second quarter valued at about $8,073,000. Bank of New York Mellon Corp bought a new position in shares of CorVel during the second quarter worth about $11,439,000. Walleye Capital LLC acquired a new position in shares of CorVel in the second quarter worth approximately $3,308,000. Canada Pension Plan Investment Board acquired a new position in shares of CorVel in the second quarter worth approximately $1,082,000. Finally, The Manufacturers Life Insurance Company acquired a new position in shares of CorVel in the second quarter worth approximately $931,000. Institutional investors and hedge funds own 51.36% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on the stock. Wall Street Zen upgraded shares of CorVel from a “buy” rating to a “strong-buy” rating in a report on Saturday. Weiss Ratings raised CorVel from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, September 1st. One analyst has rated the stock with a Hold rating. Based on data from MarketBeat.com, CorVel currently has a consensus rating of “Hold”.
Read Our Latest Research Report on CRVL
CorVel Company Profile
CorVel Corporation provides workers’ compensation and healthcare cost-management services to employers, insurers, and public entities. Its offerings are designed to help clients manage claims, coordinate care, and control healthcare-related costs. The company’s services include claims administration, medical bill review, provider network access, utilization review, case management, and pharmacy benefit management. CorVel also supports disability and liability claims management. Founded in 1987, CorVel serves customers across the United States through a combination of technology platforms and service teams.
Featured Articles
- Five stocks we like better than CorVel
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.
